Bharti Hexacom Q2 FY26 Revenue Up 10.5% YoY, EBITDA Margin at 54.2%
Bharti Hexacom reported a 10.5% YoY increase in revenue to Rs 2,317 crore for Q2 FY26. EBITDA margin improved to 54.2%, up 433 bps YoY. Mobile…
NAVA Limited Board to Consider Interim Dividend
The Board of Directors of NAVA Limited will convene to consider an interim dividend for the financial year 2025-26. The meeting, initially…
Graphite India Board to Consider Unaudited Financial Results on November 10, 2025
Graphite India has announced that a meeting of the Board of Directors will be held on November 10th, 2025, to consider and approve the…
TBO Tek Approves Financial Results for Q2 2025, Announces Acquisition
TBO Tek’s board has approved the unaudited standalone and consolidated financial results for Q2 2025. The company also announced its…
SJVN Board to Consider Quarterly and Half-Yearly Results on November 10, 2025
SJVN Limited announces a board meeting scheduled for November 10, 2025, to review and approve the financial results for the quarter and…
Gujarat Fluorochemicals Board Meeting Scheduled to Approve Quarterly Results
Gujarat Fluorochemicals has announced a board meeting scheduled for November 11, 2025, to review and approve the unaudited standalone and…
Gujarat Mineral Development Corporation Board Meeting on November 14th for Unaudited Results
Gujarat Mineral Development Corporation (GMDC) has announced a board meeting scheduled for November 14, 2025, to review and approve the…
Wockhardt Board Approves Q2 Results and Appoints New Independent Director
Wockhardt’s Board of Directors has approved the unaudited financial results for the quarter and half-year ended September 30, 2025.…
Ajanta Pharma Profit After Tax Up 20% in Q2 FY26
Ajanta Pharma reported a 20% increase in Profit After Tax (PAT) for Q2 FY26, reaching ₹260 cr. Revenue from operations grew by 14% to ₹1,354…
Rashtriya Chemicals Board Meeting to Discuss Q2 Financial Results
The Board of Directors of Rashtriya Chemicals and Fertilizers Limited will convene on November 14, 2025, to review and approve the unaudited…